# Carsten Heilmann

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/carsten-heilmann/

## Facts

| Field | Value |
| --- | --- |
| Citations | 7,861 |
| Field | Hematopoietic Stem Cell Transplantation |
| h-index | 43 |
| i10-index | 121 |
| Last Known Institution | Queen Ingrid's Hospital |
| OpenAlex ID | https://openalex.org/A5062993668 |
| ORCID iD | 0000-0002-6421-9576 |
| Works | 217 |

## Researcher papers

- [Serum Vaccine Antibody Concentrations in Children Exposed to Perfluorinated Compounds](https://scholariq.org/papers/serum-vaccine-antibody-concentrations-in-children-exposed-to-perfluorinated/)
- [Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies: report of the European experience 1968–99](https://scholariq.org/papers/long-term-survival-and-transplantation-of-haemopoietic-stem-cells-for/)
- [Colistin inhalation therapy in cystic fibrosis patients with chronic <i>Pseudomonas aeruginosa</i> lung infection](https://scholariq.org/papers/colistin-inhalation-therapy-in-cystic-fibrosis-patients-with-chronic-i/)
- [Cancer risk among patients with IgA deficiency or common variable immunodeficiency and their relatives: a combined Danish and Swedish study](https://scholariq.org/papers/cancer-risk-among-patients-with-iga-deficiency-or-common-variable/)
- [Comparison of Preparative Regimens in Transplants for Children With Acute Lymphoblastic Leukemia](https://scholariq.org/papers/comparison-of-preparative-regimens-in-transplants-for-children-with-acute/)
- [Long-term outcome following hematopoietic stem-cell transplantation in Wiskott-Aldrich syndrome: collaborative study of the European Society for Immunodeficiencies and European Group for Blood and Marrow Transplantation](https://scholariq.org/papers/long-term-outcome-following-hematopoietic-stem-cell-transplantation-in-wiskott/)
- [Estimated exposures to perfluorinated compounds in infancy predict attenuated vaccine antibody concentrations at age 5-years](https://scholariq.org/papers/estimated-exposures-to-perfluorinated-compounds-in-infancy-predict-attenuated/)
- [Reduced Antibody Responses to Vaccinations in Children Exposed to Polychlorinated Biphenyls](https://scholariq.org/papers/reduced-antibody-responses-to-vaccinations-in-children-exposed-to/)
- [Serum Vaccine Antibody Concentrations in Adolescents Exposed to Perfluorinated Compounds](https://scholariq.org/papers/serum-vaccine-antibody-concentrations-in-adolescents-exposed-to-perfluorinated/)
- [Outcome of 69 allogeneic stem cell transplantations for Fanconi anemia using HLA-matched unrelated donors: a study on behalf of the European Group for Blood and Marrow Transplantation.](https://scholariq.org/papers/outcome-of-69-allogeneic-stem-cell-transplantations-for-fanconi-anemia-using-hla/)
- [Severity of COVID-19 at elevated exposure to perfluorinated alkylates](https://scholariq.org/papers/severity-of-covid-19-at-elevated-exposure-to-perfluorinated-alkylates/)
- [Antibody response to booster vaccination with tetanus and diphtheria in adults exposed to perfluorinated alkylates](https://scholariq.org/papers/antibody-response-to-booster-vaccination-with-tetanus-and-diphtheria-in-adults/)

## Researcher topics

- [Hematopoietic Stem Cell Transplantation](https://scholariq.org/topics/hematopoietic-stem-cell-transplantation/)
- [T-cell and B-cell Immunology](https://scholariq.org/topics/t-cell-and-b-cell-immunology/)
- [Immunodeficiency and Autoimmune Disorders](https://scholariq.org/topics/immunodeficiency-and-autoimmune-disorders/)
- [Acute Lymphoblastic Leukemia research](https://scholariq.org/topics/acute-lymphoblastic-leukemia-research/)
- [Immune Cell Function and Interaction](https://scholariq.org/topics/immune-cell-function-and-interaction/)

## Researcher university

- [Queen Ingrid's Hospital](https://scholariq.org/institutions/queen-ingrid-s-hospital/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.
